NO912772L - Pyrazolidinon cck, gastrinantagonister og farmasoeytiske formuleringer derav. - Google Patents

Pyrazolidinon cck, gastrinantagonister og farmasoeytiske formuleringer derav.

Info

Publication number
NO912772L
NO912772L NO91912772A NO912772A NO912772L NO 912772 L NO912772 L NO 912772L NO 91912772 A NO91912772 A NO 91912772A NO 912772 A NO912772 A NO 912772A NO 912772 L NO912772 L NO 912772L
Authority
NO
Norway
Prior art keywords
cck
pyrazolidinon
gastrin
pharmaceutical forms
receptors
Prior art date
Application number
NO91912772A
Other languages
English (en)
Other versions
NO912772D0 (no
Inventor
Raymond Frank Brown
James Jeffry Howbert
Karen Lynn Lobb
David Andrew Neel
Jon Kevin Reel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO912772D0 publication Critical patent/NO912772D0/no
Publication of NO912772L publication Critical patent/NO912772L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D231/08—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with oxygen or sulfur atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nye substituerte pyrazolldlnoner er blitt oppdaget, og de utviser signifikant binding til cholecystoklnin (CCK) reseptorer og gastrinreseptorer l hjernen og/eller perifere steder så som bukspyttkjertel, mave og tynntarm. Forbindelsene har følgende formel: N-& eller Pyrazolldinonene er CCK og gastrinreseptorantagonlster og kan terapeutisk anvendes for behandling av mavetarm- forstyrrelser, sentralnervesystemforstyrrelser og for appetlttregulering i varmblodige vertebrater. Farmasøy- tiske formuleringer for slike indikasjoner er beskre- vet .
NO91912772A 1990-07-17 1991-07-15 Pyrazolidinon cck, gastrinantagonister og farmasoeytiske formuleringer derav. NO912772L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55348990A 1990-07-17 1990-07-17

Publications (2)

Publication Number Publication Date
NO912772D0 NO912772D0 (no) 1991-07-15
NO912772L true NO912772L (no) 1992-01-20

Family

ID=24209587

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912772A NO912772L (no) 1990-07-17 1991-07-15 Pyrazolidinon cck, gastrinantagonister og farmasoeytiske formuleringer derav.

Country Status (19)

Country Link
EP (1) EP0467614A1 (no)
JP (1) JPH04230367A (no)
KR (1) KR960005950B1 (no)
CN (1) CN1032000C (no)
AU (2) AU644190B2 (no)
BR (1) BR9103042A (no)
CA (1) CA2046672A1 (no)
CS (1) CS219391A3 (no)
FI (1) FI913431A (no)
HU (1) HUT58296A (no)
IE (1) IE912489A1 (no)
IL (1) IL98785A (no)
MX (1) MX9100164A (no)
NO (1) NO912772L (no)
NZ (1) NZ238912A (no)
PT (1) PT98323A (no)
RU (1) RU2076100C1 (no)
YU (1) YU124391A (no)
ZA (1) ZA915372B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5191084A (en) * 1991-05-01 1993-03-02 American Home Products Corporation Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents
US5153191A (en) * 1991-08-20 1992-10-06 Warner-Lambert Company Cholecystokinin antagonists useful for treating depression
US5399708A (en) * 1993-11-12 1995-03-21 Eli Lilly And Company Pyrazolidin-3-one derivatives
GB0011095D0 (en) * 2000-05-08 2000-06-28 Black James Foundation astrin and cholecystokinin receptor ligands (III)
PE20020856A1 (es) * 2001-02-13 2002-11-11 Aventis Pharma Gmbh 1,2,3,4-tetrahidronaftil aminas aciladas
UA79804C2 (en) * 2002-07-03 2007-07-25 Janssen Pharmaceutica Nv Cck-1 receptor modulators
GB0312368D0 (en) * 2003-05-30 2003-07-02 Univ Aston Novel ureido- and amido-pyrazolone derivatives
US8410135B2 (en) * 2007-06-15 2013-04-02 Solvay Pharmaceuticals B.V. 4,5 dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE530886A (no) * 1953-08-03
FR82186E (fr) * 1959-04-10 1964-01-04 Kodak Pathe Nouveau produit photographique et procédé pour le traitement de ce produit
FR2529786A1 (fr) * 1982-07-12 1984-01-13 Nativelle Sa Ets Compositions pharmaceutiques a base de derives de la pyrazolone-5, nouveaux produits et procede de preparation
DE3407506A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoline, verfahren zu ihrer herstellung und deren verwendung
EP0166355A2 (en) * 1984-06-26 1986-01-02 Merck & Co. Inc. Substituted aminophenyl compounds and acylaminophenyl compounds and pharmaceutical compositions containing them
US5089622A (en) * 1988-12-12 1992-02-18 Mitsui Toatsu Chemicals Incorporated (-)-2-pyrazoline compounds and therapeutic agent for cerebrovascular disorders containing the same as effective ingredient
US5191084A (en) * 1991-05-01 1993-03-02 American Home Products Corporation Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents

Also Published As

Publication number Publication date
MX9100164A (es) 1992-02-28
YU124391A (sh) 1994-01-20
AU8040991A (en) 1992-01-23
IL98785A0 (en) 1992-07-15
JPH04230367A (ja) 1992-08-19
IE912489A1 (en) 1992-01-29
PT98323A (pt) 1992-06-30
KR960005950B1 (ko) 1996-05-06
AU5529394A (en) 1994-04-28
EP0467614A1 (en) 1992-01-22
RU2076100C1 (ru) 1997-03-27
IL98785A (en) 1995-11-27
CA2046672A1 (en) 1992-01-18
CN1032000C (zh) 1996-06-12
AU644190B2 (en) 1993-12-02
CN1058209A (zh) 1992-01-29
FI913431A0 (fi) 1991-07-16
NO912772D0 (no) 1991-07-15
NZ238912A (en) 1992-12-23
CS219391A3 (en) 1992-02-19
FI913431A (fi) 1992-01-18
KR920002548A (ko) 1992-02-28
HUT58296A (en) 1992-02-28
ZA915372B (en) 1993-03-31
BR9103042A (pt) 1992-04-28
HU912376D0 (en) 1991-12-30

Similar Documents

Publication Publication Date Title
HUT67434A (en) Fluoroalkoxy-benzylamino derivatives of nitrogen containing heterocycles and pharmaceutical compositions containing them and process for their production
DK0613458T3 (da) Acykliske ethylendiaminderivater som substans P receptorantagonister
CA2118704A1 (en) Fused Tricyclic Nitrogen Containing Heterocycles as Substance P Receptor Antagonists
CA2109415A1 (en) Substituted 3-Aminoquinuclidines
HU9303666D0 (en) Azanorbornane derivatives
FI20000085A (fi) Menetelmä terapeuttisesti aktiivisten 4-amino-substituoitujen 2-azabicyklo/3.3.1/nonaanijohdannaisten valmistamiseksi
DE69318854T2 (de) Spiroazacyclischderivate als substanz p antagonisten
HUP0401009A2 (hu) 5-Hidroxitriptamin-6-ligandumokként alkalmazható 1-aril- vagy 1- alkil-szulfonilbenzazol-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
DK0561941T3 (da) N-Substituerede lactamer anvendelige som cholecystokinin-antagonister
NO944578L (no) Eksitatoriske aminosyre reseptor antagonister
NO912772L (no) Pyrazolidinon cck, gastrinantagonister og farmasoeytiske formuleringer derav.
NO20052124L (no) Nye 1,4-diazabisykloalkanderivater, deres fremstilling og anvendelse
DK0700384T3 (da) fremgangsmåde til fremstilling og opløsning af 2-phenyl-3-aminopiperidin
FI943499A (fi) Happokorvikkeita sisältäviä tetrahydro-1H-bentsatsepinoneja
DE69412103T2 (de) Polyamidsäure-derivate mit antigastrin wirkung, ihre herstellung und ihre verwendung als arzneimittel
EP3233830A1 (en) 1-methylpyrazole-piperazine compounds having multimodal activity against pain
DK0401093T3 (da) Hidtil ukendte pyrrolidonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende disse
KR101027556B1 (ko) 1-페닐-2-헤테로아릴-치환된 벤즈이미다졸 유도체, 면역질환의 치료용 약제를 생산하기 위한 그의 용도
RU92004363A (ru) 3-арил-3(3н)хиназолиноновые антагонисты холецистокинина и фармацевтическая композиция на их основе